- Home
- BIAF vs MDRR Comparison
BIAF vs MDRR Comparison
Compare BIAF & MDRR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BIAF
- MDRR
- Stock Information
- Founded
- BIAF 2014
- MDRR 2015
- Country
- BIAF United States
- MDRR United States
- Employees
- BIAF N/A
- MDRR N/A
- Industry
- BIAF Biotechnology: In Vitro & In Vivo Diagnostic Substances
- MDRR Real Estate Investment Trusts
- Sector
- BIAF Health Care
- MDRR Real Estate
- Exchange
- BIAF Nasdaq
- MDRR Nasdaq
- Market Cap
- BIAF 12.2M
- MDRR 13.9M
- IPO Year
- BIAF 2022
- MDRR 2018
- Fundamental
- Price
- BIAF $0.75
- MDRR $12.50
- Analyst Decision
- BIAF Hold
- MDRR
- Analyst Count
- BIAF 1
- MDRR 0
- Target Price
- BIAF N/A
- MDRR N/A
- AVG Volume (30 Days)
- BIAF 28.2M
- MDRR 1.2K
- Earning Date
- BIAF 05-14-2025
- MDRR 05-08-2025
- Dividend Yield
- BIAF N/A
- MDRR 1.72%
- EPS Growth
- BIAF N/A
- MDRR N/A
- EPS
- BIAF N/A
- MDRR 0.02
- Revenue
- BIAF $9,362,022.00
- MDRR $9,735,127.00
- Revenue This Year
- BIAF $25.19
- MDRR N/A
- Revenue Next Year
- BIAF $20.00
- MDRR N/A
- P/E Ratio
- BIAF N/A
- MDRR $659.89
- Revenue Growth
- BIAF 269.68
- MDRR N/A
- 52 Week Low
- BIAF $0.24
- MDRR $10.90
- 52 Week High
- BIAF $3.16
- MDRR $15.00
- Technical
- Relative Strength Index (RSI)
- BIAF 60.32
- MDRR 49.30
- Support Level
- BIAF $0.24
- MDRR $12.36
- Resistance Level
- BIAF $1.55
- MDRR $12.96
- Average True Range (ATR)
- BIAF 0.13
- MDRR 0.16
- MACD
- BIAF 0.08
- MDRR 0.00
- Stochastic Oscillator
- BIAF 38.64
- MDRR 36.62
About BIAF bioAffinity Technologies Inc.
bioAffinity Technologies Inc addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment. It develops proprietary noninvasive diagnostic tests and cancer therapeutics using technology that preferentially targets cancer cells and cell populations indicative of a diseased state. The company's product, CyPath Lung, is a noninvasive test for the detection of early-stage lung cancer.
About MDRR Medalist Diversified REIT Inc.
Medalist Diversified REIT Inc is engaged in the acquisition, reposition, renovation, leasing, and managing of income-producing properties with a focus on commercial properties, including flex-industrial and retail properties, multi-family residential properties, and hotel properties. The company operates as a UPREIT and owns properties through its subsidiary, Medalist Diversified Holdings, LP. Its principal objectives include sourcing value-added Investments in markets in which it maintains deep industry relationships and local market knowledge and the creation of value for stockholders by utilizing its relationships and local knowledge of commercial real estate investment, management, and disposition.